Aktie A117WV INTERSECT ENT, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen Intersect ENT, Inc.

Aktien

A117WV

US46071F1030

XENT

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Intersect ENT, Inc.(NasdaqGM:XENT) dropped from S&P Healthcare Equipment Select Industry Index
Intersect ENT, Inc.(NasdaqGM:XENT) dropped from S&P TMI Index
Intersect ENT, Inc.(NasdaqGM:XENT) dropped from S&P Global BMI Index
INTERSECT ENT, INC. : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits (form 8-K)
Medtronic Completes Purchase Of US Medical Device Group Intersect ENT
Medtronic Completes Purchase of Intersect ENT
Intersect ENT, Inc.(NasdaqGM:XENT) dropped from NASDAQ Composite Index
Hemostasis, LLC acquired Fiagon AG Medical Technologies from Intersect ENT, Inc.
Medtronic plc completed the acquisition of Intersect ENT, Inc..
INTERSECT ENT, INC. : Other Events (form 8-K)
INTERSECT ENT, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
Intersect ENT, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
INTERSECT ENT, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)
Intersect ENT, Inc. Enters into Amendment No.1 to Facility Agreement
INTERSECT ENT, INC. : Other Events (form 8-K)
INTERSECT ENT, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)
Intersect ENT, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
Intersect ENT Reports Positive Data From Real-World Evidence Study of Propel Sinus Implants
Real-World Evidence Study Demonstrates Intersect ENT’s PROPEL® Sinus Implant Reduces Healthcare Resource Utilization
Intersect ENT®, Inc. Announces Positive Results of Observational
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A117WV Aktie
  4. Nachrichten Intersect ENT, Inc.
  5. Andere Sprachen